ImmunoSEQ

Device Adaptive Biotechnologies Corporation
Total Payments
$368,550
Transactions
14
Doctors
0
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2023 $368,550 14 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $368,550 14 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
13-583_R Adaptive Biotechnologies Corporation $62,400 0
19-568_R Adaptive Biotechnologies Corporation $59,100 0
19-0339 Adaptive Biotechnologies Corporation $57,600 0
17-C-0127_R Adaptive Biotechnologies Corporation $54,600 0
MMtoALL_R Adaptive Biotechnologies Corporation $46,800 0
19-0339_R Adaptive Biotechnologies Corporation $34,800 0
00108269_R Adaptive Biotechnologies Corporation $27,000 0
2010-0991_R Adaptive Biotechnologies Corporation $22,200 0
VenetoStop_19-395 Adaptive Biotechnologies Corporation $4,050 0

Top Doctors Receiving Payments for ImmunoSEQ

Doctor Specialty Location Total Records
Unknown Bethesda, MD $368,550 14

About ImmunoSEQ

ImmunoSEQ is a device associated with $368,550 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is Adaptive Biotechnologies Corporation.

Payment data is available from 2023 to 2023. In 2023, $368,550 was paid across 14 transactions to 0 doctors.

The most common payment nature for ImmunoSEQ is "Unspecified" ($368,550, 100.0% of total).

ImmunoSEQ is associated with 9 research studies, including "13-583_R" ($62,400).